(1R)-1-({[(1R,3S,4S)-3-methoxy-4-(nitrooxy)cyclopentyl]carbonyl}oxy)ethyl 2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate | 1228545-57-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (1R)-1-({[(1R,3S,4S)-3-methoxy-4-(nitrooxy)cyclopentyl]carbonyl}oxy)ethyl 2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylate
• 英文别名: [(1R)-1-[(1R,3S,4S)-3-methoxy-4-nitrooxycyclopentanecarbonyl]oxyethyl] 2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
• CAS: 1228545-57-0
• 化学式: C₃₁H₃₄ClN₇O₈
• 分子量: 668.106
• InChiKey: ZLGYLBAGUHRRKL-YNGFEMSNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  47
• 可旋转键数：
  15
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  189
• 氢给体数：
  1
• 氢受体数：
  12

文献信息

• ANGIOTENSIN II RECEPTOR ANTAGONISTS
  申请人：Lo Michael Man-Chu

  公开号：US20100144810A1

  公开（公告）日：2010-06-10

  A compound having the structure wherein R is an angiotensin receptor antagonist active group, and Y is Y is selected from the group consisting of R 1 is selected from the group consisting of —O—C 1-6 alkyl, —O-aryl, —O-heteroaryl, —O—C 3-8 cycloalkyl, —C 1-6 alkyl, -aryl, -heteroaryl, and —C 3-8 cycloalkyl; R 2 and R 3 are independently selected from the group consisting of hydrogen and C 1-4 alkyl, or a pharmaceutically acceptable salt or hydrate thereof, which is useful for treating hypertension.

  一种具有结构的化合物，其中R是一种血管紧张素受体拮抗剂活性基团，Y是从所述群组中选择的Y，所述R1是从所述群组中选择的一种，包括—O—C1-6烷基，—O-芳基，—O-杂环芳基，—O—C3-8环烷基，—C1-6烷基，-芳基，-杂环芳基和—C3-8环烷基；R2和R3分别选择自氢和C1-4烷基的群组，或其药用盐或水合物，用于治疗高血压。
• Boron-containing small molecules
  申请人：Baker J. Stephen

  公开号：US20070155699A1

  公开（公告）日：2007-07-05

  This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.

  本发明涉及用于治疗真菌感染的化合物，更具体地用于治疗甲真菌病和/或皮肤真菌感染的局部治疗。本发明涉及的化合物对真菌具有活性，并具有使化合物与患者接触时能够到达被真菌感染的皮肤、指甲、头发、爪或蹄的特定部位的特性。特别是，本发明的化合物具有物理化学特性，有利于穿透指甲板。
• US7767657B2
  申请人：——

  公开号：US7767657B2

  公开（公告）日：2010-08-03
• US8293777B2
  申请人：——

  公开号：US8293777B2

  公开（公告）日：2012-10-23